TRINOMAB Trademark

Trademark Overview


On Tuesday, July 12, 2022, a trademark application was filed for TRINOMAB with the United States Patent and Trademark Office. The USPTO has given the TRINOMAB trademark a serial number of 79350028. The federal status of this trademark filing is REGISTERED as of Tuesday, August 13, 2024. This trademark is owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.. The TRINOMAB trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Retail store services and wholesale distributorship services featuring veterinary pharmaceutical preparations; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale distributorship services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services and wholesale distributorship services featuring pharmaceutical preparations; retail and wholesale store services featuring pharmaceutical preparations; all of the foregoing featuring monoclonal antibodies, and none of the above related to the treatment or prevention of cardiovascular diseases

Hospital services; medical assistance; nursing, medical; medical, physical rehabilitation and physical therapy services; alternative medicine services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; blood collection services, namely, collection and preservation of human blood; performing diagnosis of diseases; collection and preservation of human blood; genetic testing for medical purposes; behavioral analysis for medical purposes; rental of medical instruments and apparatus; stem cell therapy services; veterinary assistance; all of the foregoing featuring monoclonal antibodies, and none of the above related to the treatment or prevention of cardiovascular diseases

Scientific research; technological research in the field of pharmaceuticals; technological research in the fields of genetics, genetic engineering, molecular biology and cellular immunology; conducting technical project studies, namely, conducting scientific feasibility studies; scientific laboratory services; research and development of new products for others; chemical analysis; chemical research; biological research; scientific research in the nature of conducting clinical trials for others; chemistry services in the nature of chemist services; chemistry services, namely, consultation, research and advice; none of the above related to the treatment or prevention of cardiovascular diseases
trinomab

General Information


Serial Number79350028
Word MarkTRINOMAB
Filing DateTuesday, July 12, 2022
Status700 - REGISTERED
Status DateTuesday, August 13, 2024
Registration Number7470062
Registration DateTuesday, August 13, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 28, 2024

Trademark Statements


Goods and ServicesRetail store services and wholesale distributorship services featuring veterinary pharmaceutical preparations; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale distributorship services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services and wholesale distributorship services featuring pharmaceutical preparations; retail and wholesale store services featuring pharmaceutical preparations; all of the foregoing featuring monoclonal antibodies, and none of the above related to the treatment or prevention of cardiovascular diseases
Goods and ServicesHospital services; medical assistance; nursing, medical; medical, physical rehabilitation and physical therapy services; alternative medicine services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; blood collection services, namely, collection and preservation of human blood; performing diagnosis of diseases; collection and preservation of human blood; genetic testing for medical purposes; behavioral analysis for medical purposes; rental of medical instruments and apparatus; stem cell therapy services; veterinary assistance; all of the foregoing featuring monoclonal antibodies, and none of the above related to the treatment or prevention of cardiovascular diseases
Goods and ServicesScientific research; technological research in the field of pharmaceuticals; technological research in the fields of genetics, genetic engineering, molecular biology and cellular immunology; conducting technical project studies, namely, conducting scientific feasibility studies; scientific laboratory services; research and development of new products for others; chemical analysis; chemical research; biological research; scientific research in the nature of conducting clinical trials for others; chemistry services in the nature of chemist services; chemistry services, namely, consultation, research and advice; none of the above related to the treatment or prevention of cardiovascular diseases

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, September 19, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 19, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 19, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZhuhai Trinomab Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameZhuhai Trinomab Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameZhuhai Trinomab Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Friday, September 23, 2022APPLICATION FILING RECEIPT MAILED
Friday, September 16, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, September 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 26, 2023ASSIGNED TO EXAMINER
Friday, April 28, 2023NON-FINAL ACTION WRITTEN
Saturday, April 29, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, June 10, 2023LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, June 27, 2023LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Wednesday, June 28, 2023REFUSAL PROCESSED BY MPU
Wednesday, June 28, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 30, 2023ATTORNEY REVIEW COMPLETED
Saturday, July 22, 2023REFUSAL PROCESSED BY IB
Friday, September 22, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, September 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 11, 2023FINAL REFUSAL WRITTEN
Wednesday, October 11, 2023FINAL REFUSAL E-MAILED
Wednesday, October 11, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 21, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, February 21, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, March 11, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 24, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 24, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, April 24, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 24, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, May 15, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, May 28, 2024PUBLISHED FOR OPPOSITION
Wednesday, May 8, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 15, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 11, 2024NOTIFICATION PROCESSED BY IB
Tuesday, May 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2024REGISTERED-PRINCIPAL REGISTER
Saturday, March 29, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, February 1, 2025GENERIC MADRID TRANSACTION CREATED
Tuesday, August 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, November 13, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, February 1, 2025GENERIC MADRID TRANSACTION SENT TO IB